CSI Market
Sign In | Register

Neogenomics Inc (NEO) Annual Balance Sheets

Annual · GAAP · USD millions
Access NEO quarterly Balance Sheets →
The data below summarizes Neogenomics Inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent159.62
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments159.00
Accounts receivable159.24
Inventories28.57
Other Current Assets7.42
Prepaid Expense, Current AS21.44
Total Current Assets376.29
Equipment/Property/Plant Net84.83
Goodwill net524.34
Intangible Assets286.53
Other Assets, Noncurrent87.84
Debt Securities Available For Sale Excluding Accrued Interest Current0.00
Operating Lease Right Of Use Asset78.44
Total Assets1,359.83
Liabilities
Accounts Payable, Current AC23.09
Employee-related Liabilities, Current AC47.58
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current17.63
Total Current Liabilities88.30
Convertible Debt, Noncurrent LO341.86
Total Long-term Debt341.86
Other liabilities, Noncurrent12.07
Contract With Customer Liability Current0.85
Operating Lease Liability Current4.78
Deferred Income Tax Liabilities Net18.22
Operating Lease Liability Noncurrent62.82
Finance Lease Liability Noncurrent-
Total Liabilities523.27
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock1,270.24
Retained Earnings / Accumulated Deficit-433.81
Other Equity0.00
Common Stockholder's Equity836.56
Total Stockholder's Equity836.56
Liabilities & Stockholder's Equity1,359.83
4 historic quarters locked

Sign in to unlock the full Neogenomics Inc balance sheet history.

Sign In Create Free Account

About Neogenomics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: neo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001077183-26-000010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License